HIF1A and neoplasm: Furthermore, hypoxia-inducible factor-1 (HIF-1) allows cancer cells to adapt to hypoxic conditions within the TME by regulating the expression of multiple cancer stem cell markers, thereby enhancing tumour cell survival and reducing drug sensitivity [73].